AMGN

2024Q3AMC

Amgen Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2024-10-30 · Fiscal end 2024-09-30 · Features as of 2024-10-30

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS5.11
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move2.6%
IV front—
P/C full—
P/C front—
Features as of2024-10-30

Run-up

Close—
Ret 5d+0.2%
Ret 10d-1.9%
Ret 20d-1.3%
Ret 30d-5.2%

Post-Earnings Data

Results & reaction

Print

Actual EPS
5.58Beat
Estimated EPS5.11
Actual revenue
8.5B
Surprise %+9.2%
Beat / missBeat
Beat streak 41
Beat streak 81

Reaction

1-day stock reaction+0.8%
Implied vs actual

Implied 2.6%Actual 0.7%

Gap reaction+0.7%
Day result+1.5%
Next-day upYes
Realized / IV0.26×

Post tape

Post 5d+0.5%
Post 10d-7.6%
Post volume2.7M
Vol ×10d1.62×
Vol ×20d1.69×
Post range2.4%